NAMS
NewAmsterdam Pharma Company N.V.
23.20$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | 10.4% | -1,002.3% | -348.0% | -656.7% | |
| – | – | 0.0% | 0.3% | 0.2% | 1.0% | |
| – | – | 4.0% | 174.4% | 73.8% | 264.1% | |
| – | – | 10.1% | 41.6% | -71.7% | -35.3% | |
| – | – | 0.2% | 0.2% | 1.5% | 1.1% | |
| – | – | -0.2% | -0.2% | -137.9% | -777.3% | |
| – | – | 0.7% | 0.0% | 0.0% | – | |
| – | – | 381.6% | 63.3% | 1,447.5% | 131.2% | |
| – | – | 396.9% | -903.3% | 946.6% | -1,246.1% | |
| – | – | 10.2% | -1,002.4% | -349.5% | -657.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.